Optimize Your Health - Available Everywhere in the US

  188-8981-6784    HIPAA Compliant  ยท  Licensed U.S. Providers

TB-500 / Thymosin Beta-4

TB-500 โ€” Thymosin Beta-4 Fragment for Cell Migration and Tissue Biology Research. Physician-Supervised

TB-500 is a synthetic version of a fragment of thymosin beta-4 โ€” a naturally occurring protein found throughout the body that plays a key role in actin regulation and cell migration. It has been studied across multiple tissue types for its effects on the biological processes involved in repair, and is one of the most used recovery peptides in physician-supervised men’s health. It is available at OptiMale USA following thorough clinical assessment.

WHAT IS IT?

Understanding TB-500 / Thymosin Beta-4

Thymosin beta-4 (Tฮฒ4) is an endogenous 43 amino acid peptide produced throughout the body that sequesters G-actin โ€” the building block of actin filaments that drive cell movement. By regulating actin, thymosin beta-4 controls the ability of cells to migrate โ€” a fundamental biological process in tissue repair, where fibroblasts, endothelial cells, and immune cells need to move to injury sites to begin repair. TB-500 is a synthetic peptide corresponding to the active region of thymosin beta-4 responsible for this actin-regulating activity.
Research has studied TB-500 across a wide range of tissue types and injury models โ€” muscle, tendon, ligament, skin, cardiac tissue, and the central nervous system โ€” examining its effects on cell migration, angiogenesis, and extracellular matrix remodelling. Phase 2 clinical trials have examined thymosin beta-4 in specific medical contexts. At OptiMale USA, TB-500 protocols are structured individually with a loading phase followed by maintenance, based on your clinical assessment and specific recovery goals.

tb 500
Quick Facts

Injection

Timeline: Initial healing effects within 1-2 weeks; significant tissue repair at 4-8 weeks
Lab required: Yes
Ongoing maintenance: Protocol-dependent, loading phase followed by maintenance dosing
Pricing:ย  Contact for Pricing

Related Treatments

Benefits

Cell migration research

TB-500's primary investigated mechanism is actin regulation โ€” enabling repair cells to migrate efficiently to injury sites. Research has studied this cell migration effect across multiple tissue types, examining how it influences the recruitment of fibroblasts, endothelial cells, and other repair cells to damaged tissue.

Connective tissue and extracellular matrix research

Research has examined TB-500's effects on collagen deposition and extracellular matrix remodelling โ€” the structural scaffolding of connective tissue. These investigations are relevant to tendon, ligament, and fascia biology in the context of injury and repair.

Angiogenesis support

Like BPC-157, TB-500 has been studied for its effects on new blood vessel formation. Research has investigated thymosin beta-4's role in promoting angiogenesis at injury sites, supporting the restoration of blood supply to damaged tissue.

Systemic distribution via subcutaneous injection

TB-500 is administered subcutaneously and distributes systemically, allowing it to support repair biology across multiple tissue areas rather than being limited to a specific local injection site. This systemic distribution has been investigated for its relevance to whole-body recovery applications.

Who Is This For?

Am I a Good Candidate?

Ideal For

  • Men whose clinical assessment at OptiMale USA includes musculoskeletal health goals and whose provider has identified TB-500’s research profile as relevant to their individualized protocol
  • Men on broader optimisation programs whose licensed provider has recommended adding a recovery peptide component based on their health history and biomarker data
  • Men on broader optimisation programs who want to add a recovery peptide component
  • Men whose clinical assessment at OptiMale USA supports a TB-500 protocol

Not Recommended If

  • Men with active malignancy โ€” cell migration and angiogenesis promotion are contraindicated with cancer
  • Men who have not been assessed by a licensed OptiMale USA provider
  • Men with significant unmanaged health conditions
  • Men under 18
Safety

Potential Side Effects

TB-500 is generally well tolerated in research settings. Human safety data is more limited than preclinical data, though adverse effects have been rarely reported. All OptiMale USA patients are monitored throughout with clinical check-ins.

Common Questions

Frequently Asked Questions

Get started

Discuss TB-500 With a Provider

Your free consultation is the first step. A licensed OptiMale USA provider will review your bloodwork, health history, and goals before making any recommendations.

tb500

These statements have not been evaluated by the Food and Drug Administration. The information on this website is provided for educational and informational purposes only and does not constitute medical advice, a diagnosis, a treatment recommendation, or an offer to prescribe, supply, compound, administer, or dispense any product.

Compounded medications. Compounded medications, including compounded semaglutide and compounded tirzepatide, are not FDA-approved and are not generic equivalents of brand-name products such as Ozempicยฎ, Wegovyยฎ, Mounjaroยฎ, or Zepboundยฎ. The FDA does not review compounded drugs for safety, effectiveness, or quality prior to dispensing. Compounded medications are prepared by state-licensed 503A compounding pharmacies or FDA-registered 503B outsourcing facilities pursuant to a valid prescription from a licensed provider following individual patient evaluation. Availability of compounded medications varies by state and is subject to applicable state and federal law.

Research compounds. Certain compounds referenced on this website are research compounds that are not approved by the FDA for human use and have not been evaluated by the FDA for safety, efficacy, or quality. Information about these compounds is provided solely for educational and informational purposes and reflects publicly available scientific literature. OptiMale USA and its affiliated providers do not prescribe, supply, recommend, compound, administer, or dispense research compounds, and nothing on this website should be construed as an offer to do so. Patient consent forms purporting to waive provider duty of care with respect to research compounds are not recognized as a defense to professional liability and are not used by OptiMale USA.

Clinical services. All prescription products and services offered through OptiMale USA are prescribed exclusively by board-certified, licensed U.S. providers following individual clinical evaluation, comprehensive bloodwork where indicated, and a detailed health assessment. Available services and products vary by state based on provider licensure and applicable law. No provider-patient relationship is established by use of this website; a provider-patient relationship is formed only upon completion of a clinical evaluation with a licensed OptiMale USA provider.

Individual results vary. Always consult a qualified healthcare provider before beginning any new health protocol.

  • Home
  • Products
  • Solutions
  • How it Works
  • Peptide Library